Shares of Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $11.01, but opened at $10.51. Santen Pharmaceutical shares last traded at $10.51, with a volume of 384 shares.
Santen Pharmaceutical Stock Down 1.0%
The company has a 50 day simple moving average of $11.83 and a 200-day simple moving average of $11.72.
Santen Pharmaceutical Company Profile
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and commercializes prescription eye-care medicines and related products for conditions affecting vision and ocular health.
Its portfolio includes treatments for glaucoma and ocular hypertension, dry eye disease, retinal disorders, eye infections and allergies, as well as other ophthalmic conditions. Santen also conducts research in areas such as regenerative medicine and other therapies intended to address unmet needs in eye care.
Founded in Japan in 1890, Santen has expanded beyond its domestic market and serves patients and healthcare professionals across Asia, Europe and other international markets.
Featured Articles
- Five stocks we like better than Santen Pharmaceutical
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
- Is Palantir Worth $250 or $1? Bulls and Burry Arrive at Opposite Conclusions
- 3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure Builds
- Meta One Subscriptions Show Positive Early Signs, Analysts Forecast Long-Term Growth
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
